Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
Sales | 475,992 | 412,670 | 386,081 | 367,432 | 358,370 |
Cost of Goods | 245,688 | 219,945 | 202,750 | 190,256 | 186,386 |
Gross Profit | 230,304 | 192,725 | 183,331 | 177,176 | 171,984 |
Operating Expenses | 150,605 | 127,855 | 127,529 | 124,181 | 125,553 |
Operating Income | 80,387 | 65,815 | 56,552 | 53,251 | 46,817 |
Other Income | 2,867 | 2,955 | 2,229 | 4,996 | 5,728 |
Pre-tax Income | 83,254 | 68,770 | 58,781 | 58,247 | 52,545 |
Income Tax | 26,278 | 23,381 | 21,161 | 21,615 | 19,967 |
Net Income Continuous | 57,090 | 45,389 | 37,620 | 36,632 | 32,578 |
Net Income | $57,090 | $45,389 | $37,620 | $36,632 | $32,578 |
EPS Basic Total Ops | 0.42 | 0.34 | 0.28 | 0.27 | 0.21 |
EPS Basic Continuous Ops | 0.42 | 0.34 | 0.28 | 0.26 | 0.21 |
EPS Diluted Total Ops | 0.40 | 0.33 | 0.27 | 0.26 | 0.21 |
EPS Diluted Continuous Ops | 0.40 | 0.32 | 0.27 | 0.25 | 0.20 |
EBITDA(a) | $99,284 | $85,939 | $78,781 | $72,732 | $64,026 |